Abstract
To further define the metabolism of CsA, we studied the biotransformation of the drug in male and female rats using high-pressure liquid chromatographic (HPLC) analysis of CsA and primary CsA metabolites in whole blood. Moreover, we characterized the metabolism of Csa following administration of a known hepatic mixed function oxidase inducer, phenobarbital, and a commonly used, clinically relevant immunosuppressive agent, methylprednisolone.
Original language | English (US) |
---|---|
Pages (from-to) | 553-556 |
Number of pages | 4 |
Journal | Transplantation proceedings |
Volume | 20 |
Issue number | 2 SUPPL. 2 |
State | Published - Jan 1 1988 |
ASJC Scopus subject areas
- Surgery
- Transplantation